The broad-spectrum RumC1 bacteriocin targets a transient peptidoglycan intermediate of the nascent cell wall
Lutheran Medical Group · Centrale Marseille · +12 more institutions
Abstract
RumC1 is a structurally unique bacteriocin with broad-spectrum efficacy, including against multidrug-resistant pathogens, yet acting by an undefined mechanism. By integrating genetics, biochemistry, computational modeling and single-cell fluorescence microscopy, we demonstrate that RumC1 is a distinct cell-wall-targeting toxin. First, all RumC1-resistant mutants isolated through a high-rate, genome-wide mutagenic screening exhibited specific impairments in peptidoglycan homeostasis regulation, pinpointing this pathway as critical for RumC1 activity. Second, RumC1 selectively accumulates within neosynthesized peptidoglycan, leading to cell growth arrest and death in a dose-dependent manner. Third, we…
Citation impact
- FWCI
- 59.75
- Percentile
- 99%
- References
- 0
Authors
23- ABAnne Boyeldieu
Lutheran Medical Group
- MBMathieu Bergé
Lutheran Medical Group
- CRClarisse Roblin
Centrale Marseille
- LSLAMA SHAMSEDDINE
Centre National de la Recherche Scientifique, Commissariat à l'Énergie Atomique et aux Énergies Alternatives, CEA Grenoble, Institut de Recherche Interdisciplinaire de Grenoble, Laboratoire de Chimie et Biologie des Métaux, Université Grenoble Alpes
- AMAnna M. Díaz-Rovira
Barcelona Supercomputing Center, Universitat Politècnica de Catalunya
Topics & keywords
- Peptidoglycan
- Bacteriocin
- Cell wall
- Mutant
- Cell
- Peptide
- Lysis
- Cell envelope
Funding
- ANAgence Nationale de la RechercheAwards: ANR-17-EURE-0003, ANR-23-CE11-0029, ANR-17-EURE-, ANR-10-INBS-0005-02, ANR-20-CE44-0021, ANR-17, ANR-10, 17-EURE-0003, ANR-10-INBS-0005
- UDUniversité de Toulouse
- CNCentre National de la Recherche Scientifique
- MDMinisterio de Ciencia e InnovaciónAward: FPU21/03921
- FIFrench Infrastructure for Integrated Structural BiologyAwards: ANR-17-EURE-0003, ANR-10-INBS-0005, ANR-10-INBS-0005-02